March 9-11, 2026
San Diego Convention CenterSan Diego, CA, USA Tero-Pekka Alastalo, MD, PhDCEO at Avenue BiosciencesSpeaker
Profile
An experienced life science entrepreneur, investor, advisor, and board member based in San Francisco, CA, USA. Tero-Pekka Alastalo (MD, PhD) has 12+ years’ experience in life science startups and +10 years of clinical and translational research experience. His previous roles include heading North American operations at CardioSignal and co-founding Blueprint Genetics, which was acquired by Quest Diagnostics in 2020.
Agenda Sessions
Transforming Protein Biologics with High-Throughput Signal Peptide Engineering
, 12:20pmView Session